Interviews +
Thomas Wrona
Marshall, Gerstein & Borun
26 August 2015
New Marshall, Gerstein & Borun special counsel Thomas Wrona explains why licensing is often the answer in the search for new markets and products readmore

Professor Shlomo Ben-Haim
The Hobart Group
12 August 2015
Professor Shlomo Ben-Haim of The Hobart Group, an international organisation of medical device companies, explains how he became a leading entrepreneur readmore

Gabriel Di Blasi
Di Blasi, Parente & Associates
15 July 2015
Brazil has updated its examination guidelines for biotechnology products and processes. Gabriel Di Blasi of Di Blasi, Parente & Associates explains what they mean for the business and innovation readmore

Mark Mansour
Mayer Brown
01 July 2015
The pathway to regulatory approval for a drug in the US is long and painful. Mayer Brown’s Mark Mansour explains why, and ponders how it might change... readmore

Dr Paul Zagar
Blank Rome
01 July 2015
Blank Rome’s Dr Paul Zagar discusses the challenges facing global life sciences companies including, their increasing reliance on universities readmore

FIRST << 1 2 3 4 5 >> LAST

FaceBook LinkedIn RSS feed Blog Instagram Twitter
Specialist features +
Country profiles ++
Latest news +++
Matters of import
20 January 2016
Alireza Behrooz of Merchant & Gould and Nick Phillips of Edwin Coe discuss parallel importation of pharmaceuticals in the US and Europe readmore

Raising the bar
16 December 2015
Amendments to the US Civil Rules of Procedure could dissuade some non-practicing entities from targeting technology-rich sectors readmore

Making connections
02 December 2015
Changes are coming to the UK Patent Box to meet new international standards readmore

More features
06 January 2016
Australia’s IP system has come under the spotlight as the government considers possible reforms. Naomi Pearce and Nigel Lokan of K&L Gates speak to Tammy Facey readmore

11 September 2015
Mohan Dewan and Disha Dewan of R K Dewan & Co report on the ban on any changes to patent specifications or claims at the time of national phase entry via the Patent Cooperation Treaty in India readmore

11 September 2015
The fear that natural products would be privatised soon, or one cannot study a product of nature and benefit from it if another legally possesses it, is always in the minds of all stakeholders. D. Calab Gabriel and Maria Gabriel of Lex IP Care discuss the patenting of natural bio-materials in India readmore

More country profiles
AstraZeneca enters China with Plendil
02 March 2016 | London
AstraZeneca has entered into a licensing agreement with China Medical System (CMS) Holdings for the commercialisation rights in China to its calcium channel blocker, Plendil (felodipine)... readmore

Hogan Lovells boosts capabilities in Japan
01 March 2016 | Tokyo
Hogan Lovells has boosted its Japanese domestic patent capability with the hire of Hiroto Imai... readmore

Morgan Lewis bags four from K&L Gates
29 February 2016 | Chicago
Morgan Lewis has expanded its global IP team with four new partners from K&L Gates... readmore

More news

IPPro Life Sciences


Copyright (C) 2013 Black Knight Media Ltd. All rights reserved. No reproduction without prior authorization